GDPR Class Actions: Compliance now for Trial Sponsors
On December 1, 2024, the European non-profit organization noyb (None of Your Business), co-founded by privacy advocate Max Schrems,...
Diana Andrade
Privacy Now: Balancing Innovation and Privacy in Genomics
The UK’s Information Commissioner’s Office (ICO) recently issued a critical call for collaboration in genomics, emphasizing the need to...
How GDPR Drives Trust in Patient-Centric Trials
In recent years, patient-centric trial designs have emerged as a transformative approach in clinical research, placing patients at the...
New EDPB Opinion: Vendors in Clinical Trials
The European Data Protection Board (EDPB) recently issued Opinion 24/2024, focusing on a critical aspect of data protection compliance:...
Transparency and Anonymization in Research: EMA Guidelines
As the clinical trial landscape evolves under the EU Clinical Trials Regulation (CTR), transparency and privacy have become central...
EHDS & GDPR Compliance: Urgent Action Needed for Biopharma
In the rapidly evolving landscape of health data regulation, the European Health Data Space (EHDS) initiative marks a transformative...
Real-World Data in Clinical Trials: Benefits & Privacy Risks
The landscape of clinical trials is experiencing a paradigm shift with the integration of Real-World Data (RWD). Traditionally conducted...
AI in Research: Key Takeaways from the EU AI Act
Artificial Intelligence (AI) is playing an increasingly significant role in scientific research and development (R&D), particularly within the biopharmaceutical...
Top 10 Privacy Compliance Differences: US vs. EU Trials
Ensuring privacy compliance in clinical trials is crucial for protecting participants’ personal data. The regulatory frameworks in the United...
Know How to Comply With GDPR in Clinical Trials?
In the realm of clinical trials, protecting participants’ personal data is paramount. The General Data Protection Regulation (GDPR), which...